Candida endophthalmitis in non-neutropenic critically ill patients

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 15, Issue 6, 1996, Pages 503-506

  Nolla Salas, J ^a   Sitges Serra, A ^a   Leon C ^b   De La Torre, M V ^c   Sancho, H ^d  

^a HOSPITAL DEL MAR   (Spain)

^b HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^d HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE;

ADULT; AGED; ARTICLE; BLOOD CULTURE; CANDIDA; CANDIDA ALBICANS; CLINICAL ARTICLE; CLINICAL TRIAL; CRITICAL ILLNESS; DEATH; DRUG EFFICACY; ENDOPHTHALMITIS; FEMALE; HUMAN; MALE; MYCOSIS; PRIORITY JOURNAL;

AGED; CANDIDIASIS; CRITICAL ILLNESS; ENDOPHTHALMITIS; FEMALE; FUNGEMIA; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 0029955881     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01691319     Document Type: Article

References (14)

1. Edwards JE Jr, Foos RY, Montgomerie JZ, Guze LB: Ocular manifestations of Candida septicemia: review of seventy-six cases of hematogenous Candida endophthalmitis. Medicine 1974, 53: 47-75.
2. Edwards JE Jr, Filler SG: Current strategies for treating invasive candidiasis: emphasis on infections in nonneutropenic patients. Clinical Infectious Diseases 1992, 14, Supplement 1: 106-113.
3. Brooks RG: Prospective study of Candida endophthalmitis in hospitalized patients with candidemia. Archives of Internal Medicine 1989, 149: 2226-2228.
4. Parke DW, Jones DB, Gentry LO: Endogenous endophthalmitis among patients with candidemia. Ophthalmology 1982, 89: 789-796.
5. Schmid S, Martenet AC, Delz O: Candida endophthalmitis: clinical presentation, treatment and outcome in 23 patients. Infection 1991, 19: 21-24.
6. Rex JM, Bennett JE, Sugar AM, Pappas PG, van der Horst CM, Edwards JE, Washburn RG, Scheld WM, Karchmer AW, Dine AP, Levenstein MJ, Webb CD, for the Candidemia Study Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group: A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. New England Journal of Medicine 1994, 331: 1325-1330.
7. Odds FC: Candida and candidosis. Baillière Tindall, London, 1988, p. 181-186.
8. Menezes AR, Sigesmund DA, Demajo WA, Devenyi RG: Mortality of hospitalized patients with Candida endophthalmitis. Archives of Internal Medicine 1994, 154: 2093-2097.
9. Rantala A, Vaahtoranta-Lehtonen H: Hematogenous endophthalmitis in patients with postoperative septicemia. Clinical Infectious Diseases 1995, 20: 472.
10. Joshi N, Hamory BH: Endophthalmitis caused by non-albicans species of Candida. Reviews of Infectious Diseases 1991, 13: 281-287.
11. Fraser SJ, Jones M, Dunker J, Storfer S, Medoff G, Dunagan WC: Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality. Clinical Infectious Diseases 1992, 15: 414-421.
12. Cohen M, Montgomerie JZ: Hematogenous endophthalmitis due to Candida tropicalis: report of two cases and review. Clinical Infectious Diseases 1993, 17: 270-272.
13. Como JA, Dismukes WE: Oral azole drugs as systemic antifungal therapy. New England Journal of Medicine 1994, 330: 263-272.
14. Savani DV, Perfect JR, Cobo LM, Durack DT: Penetration of new azole compounds into the eye and efficacy in experimental Candida endophthalmitis. Antimicrobial Agents and Chemotherapy 1987, 31: 6-10.